[go: up one dir, main page]

ITMI20062286A1 - Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi - Google Patents

Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi

Info

Publication number
ITMI20062286A1
ITMI20062286A1 IT002286A ITMI20062286A ITMI20062286A1 IT MI20062286 A1 ITMI20062286 A1 IT MI20062286A1 IT 002286 A IT002286 A IT 002286A IT MI20062286 A ITMI20062286 A IT MI20062286A IT MI20062286 A1 ITMI20062286 A1 IT MI20062286A1
Authority
IT
Italy
Prior art keywords
gynecological
administration
composition
well
biologically active
Prior art date
Application number
IT002286A
Other languages
English (en)
Inventor
Luca Mogna
Gian Paolo Strozzi
Original Assignee
Anidral Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anidral Srl filed Critical Anidral Srl
Priority to IT002286A priority Critical patent/ITMI20062286A1/it
Priority to RU2009121623/15A priority patent/RU2445073C2/ru
Priority to ES07825668.2T priority patent/ES2626841T3/es
Priority to US12/516,512 priority patent/US20100092440A1/en
Priority to CA2670578A priority patent/CA2670578C/en
Priority to DK07825668.2T priority patent/DK2120864T3/en
Priority to EP07825668.2A priority patent/EP2120864B1/en
Priority to BRPI0719549A priority patent/BRPI0719549B8/pt
Priority to PCT/IB2007/003491 priority patent/WO2008065492A2/en
Priority to PL07825668T priority patent/PL2120864T3/pl
Priority to JP2009538800A priority patent/JP5535641B2/ja
Publication of ITMI20062286A1 publication Critical patent/ITMI20062286A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT002286A 2006-11-28 2006-11-28 Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi ITMI20062286A1 (it)

Priority Applications (11)

Application Number Priority Date Filing Date Title
IT002286A ITMI20062286A1 (it) 2006-11-28 2006-11-28 Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
RU2009121623/15A RU2445073C2 (ru) 2006-11-28 2007-11-12 Композиция для введения биологически активных веществ во влагалище и прямую кишку и ее применения
ES07825668.2T ES2626841T3 (es) 2006-11-28 2007-11-12 Composición para la administración de principios biológicamente activos en el campo ginecológico y rectal y usos de la misma
US12/516,512 US20100092440A1 (en) 2006-11-28 2007-11-12 composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof
CA2670578A CA2670578C (en) 2006-11-28 2007-11-12 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof
DK07825668.2T DK2120864T3 (en) 2006-11-28 2007-11-12 A COMPOSITION OF THE ADMINISTRATION OF BIOLOGICAL ACTIVE INGREDIENTS IN THE GYNECOLOGY AND RECTAL FIELD AND APPLICATIONS THEREOF
EP07825668.2A EP2120864B1 (en) 2006-11-28 2007-11-12 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof
BRPI0719549A BRPI0719549B8 (pt) 2006-11-28 2007-11-12 composição para administração de princípios biologicamente ativos no âmbito ginecológico e retal, e usos para as mesmas
PCT/IB2007/003491 WO2008065492A2 (en) 2006-11-28 2007-11-12 A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof
PL07825668T PL2120864T3 (pl) 2006-11-28 2007-11-12 Kompozycja do podawania składników biologicznie czynnych w okolicy narządów płciowych i odbytnicy, i jej zastosowania
JP2009538800A JP5535641B2 (ja) 2006-11-28 2007-11-12 婦人科および直腸科分野における生物活性成分投与のための組成物とその使用方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT002286A ITMI20062286A1 (it) 2006-11-28 2006-11-28 Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi

Publications (1)

Publication Number Publication Date
ITMI20062286A1 true ITMI20062286A1 (it) 2008-05-29

Family

ID=39468316

Family Applications (1)

Application Number Title Priority Date Filing Date
IT002286A ITMI20062286A1 (it) 2006-11-28 2006-11-28 Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi

Country Status (11)

Country Link
US (1) US20100092440A1 (it)
EP (1) EP2120864B1 (it)
JP (1) JP5535641B2 (it)
BR (1) BRPI0719549B8 (it)
CA (1) CA2670578C (it)
DK (1) DK2120864T3 (it)
ES (1) ES2626841T3 (it)
IT (1) ITMI20062286A1 (it)
PL (1) PL2120864T3 (it)
RU (1) RU2445073C2 (it)
WO (1) WO2008065492A2 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1403661B1 (it) * 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
US9987222B2 (en) 2012-01-31 2018-06-05 Biosoma B.V. Method for administration of a probiotic
ITMI20130794A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche.
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130793A1 (it) 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
ITMI20131280A1 (it) * 2013-07-30 2015-01-31 Probiotical Spa Produzione di materie prime e prodotti finiti atossici testati mediante un metodo innovativo a base di batteri probiotici per la determinazione della tossicità verso i batteri probiotici.
WO2016020861A2 (pt) * 2014-08-05 2016-02-11 Palmeira De Oliveira Ana Cristina Composição vaginal para tratamento e prevenção de infeções urogenitais, processos de obtenção e suas aplicações
MA45334A (fr) 2016-03-24 2019-01-30 Probiotical Spa Composition bactérienne d'acide lactique pour le traitement d'infections vaginales bactériennes par gardnerella vaginalis et, éventuellement, d'infections fongiques concurrentes
CA3048669A1 (en) 2016-12-15 2018-06-21 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for modulating growth of a genetically modified gut bacterial cell
WO2018143678A1 (ko) * 2017-01-31 2018-08-09 경희대학교 산학협력단 신규 유산균 및 이의 용도
ES2884072T1 (es) * 2019-01-18 2021-12-10 Cp Kelco Us Inc Composición prebiótica y su uso
CN112813011A (zh) * 2021-03-23 2021-05-18 北京宝源广通科技发展有限公司 一种干酪乳杆菌及其在制备水苏糖合生元酸奶中的应用
CN113558246B (zh) * 2021-07-21 2023-10-20 石河子大学 一种共生双歧杆菌复合微胶囊及制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK242083D0 (da) * 1983-05-27 1983-05-27 Hansens Chr Bio Syst Vaginalkapsler
JPH06101994B2 (ja) * 1989-08-16 1994-12-14 ユニコロイド株式会社 耐消化性腸内有用細菌及びその製法
DE4123330A1 (de) * 1991-07-15 1993-01-21 Gerhard Netz Verfahren zur peranalen keimapplikation
JPH05262657A (ja) * 1992-01-22 1993-10-12 Miyarisan Seibutsu Igaku Kenkyusho:Kk 酪酸菌含有液剤の製造法
US5292534A (en) * 1992-03-25 1994-03-08 Valentine Enterprises, Inc. Sustained release composition and method utilizing xanthan gum and an active ingredient
US5531989A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
US6093394A (en) * 1997-04-11 2000-07-25 Gynelogix, Inc. Vaginal lactobacillus medicant
JPH1121231A (ja) * 1997-07-03 1999-01-26 Okamoto Ind Inc 水溶性潤滑剤
DK0956858T3 (da) * 1998-04-30 2002-01-28 Vesely Renata Maria Cavaliere Farmaceutiske præparater indeholdende lactobacilli til behandling af vaginale infektioner
JP2003128588A (ja) * 2001-08-10 2003-05-08 Toray Ind Inc 多糖類含有組成物およびその用途
DK1429802T3 (da) * 2001-09-28 2013-02-18 Tntgamble Inc Tilførselssystem for biologisk komponent
WO2005060937A1 (en) * 2003-12-23 2005-07-07 Chr. Hansen A/S Compressed tablets comprising viable probiotic microorganisms

Also Published As

Publication number Publication date
JP5535641B2 (ja) 2014-07-02
JP2010511033A (ja) 2010-04-08
RU2009121623A (ru) 2011-01-10
BRPI0719549B8 (pt) 2021-05-25
US20100092440A1 (en) 2010-04-15
CA2670578A1 (en) 2008-06-05
EP2120864A2 (en) 2009-11-25
DK2120864T3 (en) 2017-05-01
EP2120864B1 (en) 2017-03-22
RU2445073C2 (ru) 2012-03-20
WO2008065492A3 (en) 2009-03-19
CA2670578C (en) 2016-01-26
PL2120864T3 (pl) 2017-08-31
BRPI0719549B1 (pt) 2020-05-19
BRPI0719549A2 (pt) 2014-01-21
ES2626841T3 (es) 2017-07-26
WO2008065492A2 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
ITMI20062286A1 (it) Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi
EP1944277A4 (en) ANTI-ARTICLE AND ANTIBACITY COMPOSITION
EP2004194A4 (en) AZOXYSTROBINFORMULIERUNGEN
BRPI0810323A2 (pt) "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"
ITMI20050729A1 (it) Nuova formulazione biologicamente attiva
GB2424833B (en) Anti-inflammatory formulation comprising apocyanin and paeonol
EP1914273A4 (en) ETHER COMPOSITION AND SOLUTION COMPOSITION
MA28846B1 (fr) Composition biologiquement active
ITMI20051027A1 (it) Architettura per implementare una capacita' integrata
IL185096A0 (en) Polymer compositions and their use in the production of active or effective ingredient compositions
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
DK1798234T3 (da) Farmaceutisk sammensætning omfattende temozolomidester
CL2007003277A1 (es) Compuestos derivados de sulopenem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
ITMI20040011A1 (it) Principi attivi antiinfiammatori nei fanghi termali euganei
ITMI20061522A1 (it) Composizione ad attivita' antiossidante ed antiglicante migliorata
FR2887541B1 (fr) Compositions d'inertage d'impuretes
ITAL20060015A1 (it) Tracciabilita' di persone in aree ristrette
ITMI20050195U1 (it) Utensile gira-maschi ad elevata praticita' d'impiego
UA14417S (uk) Крісло м'яке
UA13162S (uk) Крісло м'яке
UA13157S (uk) Крісло м'яке
UA13150S (uk) Крісло м'яке
UA14522S (uk) Крісло м'яке
UA14422S (uk) Крісло м'яке
UA13154S (uk) Крісло м'яке